-
ABOUT USHebei Guangxiang Pharmaceutical Co., Ltd. is specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.
-
News CenterAt the forefront of corporate development, we champion the positive energy of the Four Pharmaceutical Companies: fulfilling our duties conscientiously, stepping up to the plate and taking proactive action, embracing new missions, and conducting effective new publicity. In doing so, we aim to enhance the overall competence of our employees, stimulate their enthusiasm, initiative, and creativity, and provide robust ideological guidance and powerful spiritual strength to drive the enterprise forward.
-
INNOVATIONDevelops fine, series, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages.
-
-
RECRUITGuangxiang has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities.
-
CONTACTWith stable production, high-quality and reliable service, the company's products have been sold to more than 80 countries such as the United States, the United Kingdom, Germany and the Netherlands
Hebei Guangxiang Pharmaceutical Co,. Ltd.
It is a super-large professional pharmaceutical enterprise mainly engaged in the production of bulk APIs, specialty APIs, intermediate compounds and biomedical preparations, being a subsidiary of the SSY Group, and has successively won the honorary titles of "Hebei Science and Technology Small and Medium-sized Enterprise", "Hebei High-tech Enterprise", "Hebei Enterprise Technology Center", "Hebei Green Factory" and "Hebei Specialized and Special New Demonstration Enterprise".
Production of 200 bulk and specialty active pharmaceutical ingredients
Products are exported to more than 80 countries.
Covering a total area of over 1,000 mu.
Shijiazhuang Sihua Pharmaceutical Group has invested 3 billion yuan to build
High-end API innovation and scientific research platform
Adhering to the innovative idea of "combination of imitation and innovation", we continue to increase investment in new product research and development, creating high-end innovation platforms relying on the support from Hebei Enterprise Technology Center, Hebei Technology Innovation Center, Postdoctoral Research Workstation and other high-end innovation platforms, we are actively promoting the integration of innovative production process, through overcoming key technologies such as bulk pharmaceutical synthesis, developing refined, serialized, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages
Building a National Hub for API Innovation
Developing sophistication, product line diversification, and high-end offerings, among others.
Develop high-value-added and innovative active pharmaceutical ingredients to establish competitive advantages across product categories.
To promote the cause of human health with strength from China
Join Us+
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home